Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Costunolide-Induced Apoptosis via Promoting the Reactive Oxygen Species and Inhibiting AKT/GSK3β Pathway and Activating Autophagy in Gastric Cancer
Cuixiang Xu, Xiaoyan Huang, Xiaohua Lei, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 18

Showing 18 citing articles:

Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis
Chou‐Yi Hsu, Sadegh Rajabi, Maryam Hamzeloo‐Moghadam, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
The signaling pathways and targets of natural products from traditional Chinese medicine treating gastric cancer provide new candidate therapeutic strategies
Yile Liao, Yu Gui, Qingzhou Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188998-188998
Closed Access | Times Cited: 20
Mechanisms of Traditional Chinese Medicine in the Treatment and Prevention of Gastric Cancer
Yanyang Liu, Xuefei Yu, Huize Shen, et al.
Phytomedicine (2024) Vol. 135, pp. 156003-156003
Open Access | Times Cited: 7
PD15, a steroidal saponin, induces apoptosis of HCT116 colorectal cancer cells via suppressing the Akt/GSK3β pathway
Minna Yao, Yi Ding, Yang Sun, et al.
Journal of Pharmacy and Pharmacology (2025)
Closed Access
Investigation of Molecular Mechanisms Involved in Sensitivity to the Anti-Cancer Activity of Costunolide in Breast Cancer Cells
Yu‐Jeong Choi, Youn Kyung Choi, Seong‐Gyu Ko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4009-4009
Open Access | Times Cited: 10
Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways
Chi Teng, Jiawen Chen, Lisha Shen, et al.
Cancer Drug Resistance (2025)
Open Access
Costunolide alleviates hyperglycaemia‐induced diabetic cardiomyopathy via inhibiting inflammatory responses and oxidative stress
Bo Jin, Yi Chen, Jiong Wang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 6, pp. 831-845
Open Access | Times Cited: 8
Research Progress on the Homologous Effects of Cichorium glandulosum Boiss. et Huet on Medicine and Food: A Review
Jian Yang, Yi Lei, Junlin Yan, et al.
Natural Product Communications (2024) Vol. 19, Iss. 4
Open Access | Times Cited: 2
Costunolide alleviates atherosclerosis in high-fat diet-fed ApoE−/− mice through covalently binding to IKKβ and inhibiting NF-κB-mediated inflammation
Zhuqi Huang, Wu Luo, Weixin Li, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 1, pp. 58-70
Open Access | Times Cited: 11
Optimized bilosome-based nanoparticles enhance cytotoxic and pro-apoptotic activity of costunolide in LS174T colon cancer cells
Abdulmohsin J. Alamoudi, Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115757-115757
Open Access | Times Cited: 6
Inhibition of STX17–SNAP29–VAMP8 complex formation by costunolide sensitizes ovarian cancer cells to cisplatin via the AMPK/mTOR signaling pathway
Xiao Liang, Chunlei Yu, Yunhong Tian, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115549-115549
Closed Access | Times Cited: 4
Thioredoxin system in colorectal cancer: Its role in carcinogenesis, disease progression, and response to treatment
Nurul Akmaryanti Abdullah, Nur Fariesha Md Hashim, Noraina Muhamad Zakuan, et al.
Life Sciences (2024) Vol. 348, pp. 122711-122711
Closed Access | Times Cited: 1
Novel Strategies for Tumor Treatment: Harnessing ROS-Inducing Active Ingredients from Traditional Chinese Medicine Through Multifunctional Nanoformulations
Zhengguang Zhang, M. Y. Li, Xiaolong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9659-9688
Open Access | Times Cited: 1
Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy
Cong Xu, Shaodi Wen, Xiaoyue Du, et al.
Pharmacological Research (2024), pp. 107553-107553
Open Access | Times Cited: 1
Susceptibility of HPV-18 Cancer Cells to HIV Protease Inhibitors
Lilian Makgoo, Salerwe Mosebi, Zukile Mbita
Viruses (2024) Vol. 16, Iss. 10, pp. 1622-1622
Open Access
Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells
Weibin Hu, Yiting Liu, Jing Li, et al.
Toxicology in Vitro (2024) Vol. 99, pp. 105867-105867
Closed Access
Guanine nucleotide exchange factor T exerts the cancer-promoting function in cholangiocarcinoma by enhancing the Wnt-GSK-3β-β-catenin cascade via regulation of Rac1/Cdc42
Xifang Wang, Xiaomin Zhang, Jingying Sun, et al.
Toxicology and Applied Pharmacology (2023) Vol. 467, pp. 116492-116492
Closed Access
Clinicopathological significance and molecular mechanism of AKT/GSK3β pathway-based fibrillin-1 expression in gastric cancer progression
Yong Zhang, Qiyu Zhao, Yufeng Ren, et al.
Cellular and Molecular Biology (2022) Vol. 68, Iss. 8, pp. 57-63
Open Access
Page 1

Scroll to top